Company Filing History:
Years Active: 2006-2019
Title: Heather Streeter: Innovator in Myelin Oligodendrocyte Glycoprotein Research
Introduction
Heather Streeter is a prominent inventor based in Bristol, GB, known for her significant contributions to the field of biomedical research. With a total of 8 patents to her name, she has made remarkable strides in understanding and utilizing myelin oligodendrocyte glycoprotein (MOG) peptides for therapeutic applications.
Latest Patents
Among her latest patents, Heather has developed peptides capable of binding to MHC molecules in vitro and being presented to T cells without antigen processing. These peptides, which include MOG 41-55, 43-57, 44-58, and 45-59, are crucial for advancing treatments for various diseases. Her work emphasizes the potential use of these peptides in pharmaceutical compositions and methods for treating and preventing diseases.
Career Highlights
Heather has worked with notable companies such as Apitope Technology (Bristol) Limited and Apitope Technology Limited. Her innovative research has positioned her as a key figure in the development of new therapeutic strategies involving MOG peptides.
Collaborations
Heather has collaborated with esteemed colleagues, including David Wraith and Mary Ponsford, further enhancing her research and contributions to the field.
Conclusion
Heather Streeter's work in the realm of myelin oligodendrocyte glycoprotein peptides showcases her dedication to advancing medical science. Her patents and collaborations reflect her commitment to innovation and the potential for impactful treatments in healthcare.